Background-Little is known about the association of scavenger receptor class B type I (SCARB1) single-nucleotide polymorphisms (SNPs) and subclinical atherosclerosis, particularly in subjects of different racial/ethnic backgrounds. We examined this relationship in the Multi-Ethnic Study of Atherosclerosis. Methods and Results-Forty-three SCARB1-tagging SNPs were genotyped. Baseline examinations included fasting lipids and subclinical atherosclerosis phenotypes (coronary artery calcification, common carotid intimal-medial artery thickness [CCIMT], and internal carotid intimal-medial artery thickness). Examining SNP associations with different subclinical atherosclerosis phenotypes across multiple racial/ethnic groups with adjustment for multiple covariates, we found that the C allele of SNP rs10846744 was associated with higher CCIMT in African American (Pϭ0.03), Chinese (Pϭ0.02), European American (Pϭ0.05), and Hispanic participants (Pϭ0.03) and was strongly associated in pooled analyses (Pϭ0.0002). The results also showed that the association of this SNP with CCIMT was independent of lipids and other well-established cardiovascular risk factors. Stratifying by sex, there seemed to be a strong association of rs10846744 with CCIMT in women, but no genotype-sex interactions were observed. Conclusions-Variation in SCARB1 at rs10846744 was significantly associated with CCIMT across racial/ethnic groups in Multi-Ethnic Study of Atherosclerosis. (Circ Cardiovasc Genet. 2010;3:47-52.)
H igh-density lipoprotein cholesterol (HDL-C) has been established as protective against atherosclerosis and cardiovascular disease (CVD). 1,2 HDL-C levels are heritable, with a recent heritability estimate of 50% in a study of twins of Northern European background. 3 Polymorphisms in a number of genes involved in HDL-C-regulating pathways have been shown to influence risk of subclinical atherosclerosis (SCA) 4, 5 and CVD. 6, 7 Clinical Perspective on p 52
One gene, SCARB1, encodes scavenger receptor class B type I (SR-BI), which is a key lipoprotein receptor, binding lipoproteins with high affinity and participating in the selective transfer of neutral lipids from the lipoprotein core. 8, 9 In humans, studies have shown SCARB1 single-nucleotide polymorphisms (SNPs) to be associated with lipid levels 10 -13 and lipoprotein particle size. 12, 14 One recent study of SCARB1 variants in the Genetics of Lipid Lowering Drugs and Diet Network trial found that the exon 1 SNP rs4238001 was associated with differences in HDL-C (Pϭ0.01) and triglyceride levels (Pϭ0.004) after an intervention with lipid-lowering fenofibrate. 15 Several studies have suggested that the effects of SCARB1 variants on lipids to be sex specific. In 1 study, the rs4238001 SNP was significantly associated with higher HDL-C and lower low-density lipoprotein cholesterol but only in men. 10 In postmenopausal women in the Rancho Bernardo Study, multiple SCARB1 SNPs were significantly associated with HDL-C levels among women taking estrogen therapy. 16 We reported a significant association of an exon 8 synonymous coding SNP, rs5888, and a nonsynonymous coding SNP, rs5891 (V135I, valine-toisoleucine substitution), with HDL-C levels in female participants in the Amish Family Diabetes Study. 17 Research in mouse models has suggested sex-specific effects in the role of SCARB1 in coronary artery disease, 18 and accelerated atherosclerosis has been reported in Scarb1 null female mice. 19 Although the role of SR-BI in protecting against atherosclerosis has been well established in mouse models, 20 its role in human susceptibility to atherosclerosis has not been extensively studied. One previous study has directly tested the association of SCARB1 coding variants with measures of SCA and observed an association of the rs4238001 SNP with internal carotid intimal-medial thickness (ICIMT). 21 Two common variants in intron 5 and exon 8 of SCARB1 were found to be associated with extreme triglyceride-to-HDL-C ratios in women with premature coronary artery disease. 12 Similarly, Rodriguez-Esparragon et al 18 identified an association of rs5888 with coronary artery disease.
Markers of SCA, including CIMT and coronary artery calcification (CAC), have been shown to be associated with CVD prevalence [22] [23] [24] and numerous cardiovascular risk factors. 22, 23, 25 Common carotid intimal-medial thickness (CCIMT), in particular, was reported in the Rotterdam Elderly Study (a study of 7983 subjects aged 55 years or older) to be associated with risk of myocardial infarction and stroke. 26 The investigation of genetic associations with markers of SCA, such as CCIMT, may help in identifying candidate genes for CVD and elucidating the pathological mechanisms through which these candidates may exert their role on disease risk.
In this study, we examined SNPs genotyped in SCARB1 and markers of SCA in the 4 racial/ethnic groups of the Multi-Ethnic Study of Atherosclerosis (MESA) to determine (a) whether or not genetic variation in SCARB1 is associated with SCA, (b) whether the role of SCARB1 variants in SCA may be mediated by their effects on lipid levels, and (c) whether the associations of SCARB1 variants with SCA are modified by gender.
Methods

Study Design
The recruitment and design of the MESA has been described previously. 27 The MESA is a longitudinal prospective cohort study designed to investigate the prevalence and progression of subclinical CVD. Beginning in July 2000, MESA enrolled 3601 women and 3213 men aged 45 to 84 years without previous evidence of CVD from 4 racial/ethnic groups. The racial/ethnic composition is 38% European American (EUA), 28% African American (AFA), 22% Hispanic (HIS), and 12% Asian of Chinese descent (CHN), with participants from 6 US communities (Baltimore, Md; Chicago, Ill; Forsyth County, NC; Los Angeles County, Calif; upper Manhattan, N.Y.; and St Paul, Minn). Institutional review board approval was obtained at all sites. The current analysis examines a sample (nϭ2757) from the overall baseline MESA cohort who were randomly selected from the 6814 MESA participants for genotyping. All participants in this subgroup provided a written consent to the use of their DNA and collection of phenotype data (genotyping and laboratory analyses; see online-only Data Supplement, which includes a complete description of polymorphisms [supplemental 
Statistical Analysis
To test the association of SCARB1 SNPs with SCA markers (CCIMT, ICIMT, and CAC), genotypic tests of association were performed, assuming an additive genetic model. Pairwise SNP linkage disequilibrium (LD) was estimated with r 2 and DЈ within each racial/ethnic group (AFA, CHN, EUA, and HIS) using Haploview version 4.0 28 (supplemental Figures I and II) , with haplotype blocks defined by the method of Gabriel et al. 29 Genotypic associations of the quantitative traits CCIMT and ICIMT and the binary trait CAC were examined in 2757 participants (712 AFA, 630 CHN, 711 EUA, and 704 HIS) using linear and logistic regression models adjusted for age, sex, and MESA recruitment site (model 1) and stratified by racial/ethnic group. To determine whether the effects of any variants that demonstrate associations with SCA phenotypes may be moderated by the role of SCARB1 variation in lipid levels, initial genotypic associations were followed up with additional adjustment for multiple covariates (HDL-C, low-density lipoprotein cholesterol, triglycerides) and other cardiovascular risk factors (body mass index, glucose levels, and hypertension) (model 2). Genotypic analyses were performed using PLINK software. 30 To account for multiple hypothesis testing and allow statistically significant association at ␣ϭ0.05, empirical P values from simulation were estimated in PLINK using the "-mperm" option and are reported in this study for each independent test of association using 20 000 simulation replicates. All P values reported for tests of association are empirical P values unless otherwise stated and are denoted by P e . P e values were estimated across the gene using a max(T) approach to better account for the examination of multiple phenotypes in multiple racial/ethnic groups. For any SNPs demonstrating associations with the same phenotype across 3 or more groups at or below the empirically adjusted ␣ϭ0.05, we performed joint modeling after adjusting for racial/ethnic group and including a term for genotyperace interaction.
Results
MESA Baseline Characteristics
Baseline characteristics of subjects in the 4 racial/ethnic groups of the MESA cohort who were genotyped for SCARB1 SNPs are shown in Table 1 . For the entire group, the mean age with SD was 61.6Ϯ9.9 years, 54% were women, and the meanϮSD body mass index was 28.0Ϯ5.5 kg/m 2 . Mean levels of most lipids and SCA markers significantly differed among the 4 ethnic groups (PϽ0.0001 to PϽ0.001). Of the SCA phenotypes, the AFA group had the highest mean CCIMT and ICIMT measurements, whereas the CHN group had the lowest levels. However, CAC frequency was highest in the EUA and lowest in the AFA groups.
Associations of SCARB1 SNPs With Markers of SCA
We first examined the associations of SNPs (Figure) with SCA phenotypes after adjusting for age, sex, and MESA center. Although a number of significant SNP associations were observed in each racial/ethnic group for all SCA phenotypes examined, no significant SNP associations were observed across all groups for either ICIMT or CAC. Similar results were observed when the associations were adjusted for lipid levels and other major CVD risk factors (model 2; supplemental Figure III) .
Several variants demonstrated associations with CCIMT across multiple racial/ethnic groups, specifically intron 1 SNPs rs10846744 and rs10744182. For SNP rs10846744, the C allele was significantly associated with higher CCIMT (Table 2) in the AFA (P e ϭ0.02), CHN (P e ϭ0.03), and HIS (P e ϭ0.003) groups, with a nonsignificant trend in the same direction in the EUA group (P e ϭ0.10) as well.
To more fully confirm this relationship, the genotypic association of rs10846744 with CCIMT was examined by pooling data across all racial/ethnic groups. The C allele was significantly associated with higher CCIMT across all groups at P e ϭ0.0002 (nominal Pϭ2.5ϫ10 Ϫ5 ) after adjustment for ethnicity. Genotype-race interactions were modeled to test for heterogeneity between genotypic associations among racial/ ethnic groups; however, no significant interaction was observed (P e ϭ0.98).
To determine whether the association of rs10846744 with CCIMT might be mediated through lipids or through other CVD risk factors, we examined the association of this SNP with CCIMT under model 2 adjustments and observed the change in regression coefficient values within each racial group ( Table 2) . The values of regression coefficients mod- Data are presented as n (%) or meanϮSD. To convert glucose to mg/dL, divide by 0.0555; to convert cholesterol to mg/dL, divide by 0.0259; and to convert triglycerides to mg/dL, divide by 0.0113. BMI indicates body mass index and LDL-C, low-density lipoprotein cholesterol. estly changed across most racial/ethnic groups, and significant association with CCIMT remained for the C allele of the rs10846744 SNP across all 4 racial/ethnic groups (AFA, P e ϭ0.03; CHN, P e ϭ0.02; EUA, P e ϭ0.05; and HIS, P e ϭ0.03).
We found limited LD between rs10846744 and other SCARB1 SNPs in the AFA, CHN, and HIS groups (supplemental Figures I and II) ; therefore, we did not examine any haplotypic or other genotypic associations in these groups. However, in the EUA group, we found that 2 SNPs in an LD block with rs10846744 showed evidence of similar association with CCIMT, with rs2343394 significantly associated (P e ϭ0.02) and rs1902560 associated with borderline significance (P e ϭ0.08) with CCIMT under model 2 adjustments (data not shown).
Sex-Stratified Association of SNPs With SCA Markers
We examined whether sex-specific effects were present in the association of SCARB1 SNPs with SCA phenotypes by testing genotype-sex interactions, modeled additively and adjusted for age, and MESA site (model 1), as shown in supplemental Table II . No statistically significant genotypesex interactions were observed across multiple racial/ethnic groups. Examining differences in patterns of association stratifying by sex, associations of individual SNPs with CAC (supplemental Table III ), CCIMT (supplemental Table IV) , and ICIMT (supplemental Table V ) suggested stronger associations of SCARB1 variation with SCA among women than among men. Few significant associations within each sex were observed across multiple racial/ethnic groups, with a notable exception. The rs10846744 SNP, which demonstrated significant associations in the overall analysis with CCIMT, also demonstrated significant associations with CCIMT among women in the same groups (AFA, P e ϭ0.02; CHN, P e ϭ0.009; and HIS, P e ϭ0.009); however, no significant genotype-sex interactions were observed (AFA, P e ϭ0.55; CHN, P e ϭ0.18; EUA, P e ϭ0.90; and HIS, P e ϭ0.82).
Discussion
We had 3 objectives for this study: (1) to determine whether or not variants of SCARB1 are associated with SCA in MESA, (2) whether the role of SCARB1 variants in SCA may be mediated by their effects on lipid levels, and (3) whether the association of SCARB1 variants with SCA was modified by gender. We have now shown that certain SCARB1 variants are associated with SCA, specifically the C allele of rs10846744 with CCIMT. For the rs10846744 variant, its association with CCIMT did not seem to be mediated through traditional lipid measurements. We observed that this SNP was more strongly associated with CCIMT in women than in men across all 4 MESA racial/ethnic groups.
That we observed significant associations of a number of SCARB1 SNPs with different SCA measurements in the 4 racial/ethnic groups is consistent with the results from Fox et al. 21 Following up a genomewide linkage analysis with fine mapping and association testing in SCARB1, these researchers found that those homozygous for the rare allelic variants of the nonsynonymous SNP rs4238001 had lower CIMT. In our study, we observed a number of SNPs associated with CCIMT, ICIMT, or CAC in different racial/ethnic groups, but only the rs10846744 was significantly associated with CCIMT across multiple groups. The lack of multiple genetic associations with SCA that are consistent across the 4 groups may be due to differences in the LD structure among the groups; however, it is not known whether and to what extent variation at multiple sites in SCARB1 may affect SCARB1 function. In contrast, variation at rs10846744 may represent the strongest direct or indirect association signal (especially in the pooled analysis) for a causal allele associated with CCIMT.
We did not find that traditional lipid measurements affected the association of rs10846744 with CCIMT. It is known that SR-BI can affect nitric oxide synthesis in the vessel wall 27 ; thus, the effects of SR-BI on atherosclerosis might not all be directly mediated by lipid effects. Alternatively, the influence of SCARB1 variants on SCA might not be adequately explained by traditional lipid measurements but instead by lipid subfractions or other measures of lipoprotein compositional changes.
We 17 and others 16 had reported previously significant differences in the association of SCARB1 variants with lipids stratified either by gender or by genotype-sex interaction. We observed sex-specific association of rs10846744 with CCIMT, which was more strongly associated in women than in men across multiple MESA racial/ethnic groups; however, with this exception, limited additional evidence in the MESA cohort was observed for sex differences in the associations of SCARB1 variants with SCA. It is possible that the lack of sex differences observed is due to diminished power in the analyses after stratifying by sex, although it is also possible that true sex-specific effects in SCARB1 (especially for rs10846744) may not be easily explained by the data. The availability of results from the larger Candidate-gene Association Resource Study (CARe) study within the next year should provide sufficient power to answer the question of whether associations of SCARB1 variants with SCA are modified by gender. Given evidence from previous work, such as a study of SR-BI knockout mice that showed that the female mice are more prone to accelerated atherosclerosis and infertility than the male mice, 31 further examination of sex differences in the effect of SCARB1 variants on SCA is merited.
The limitations of our study merit discussion. We were unable to examine SCARB1 associations with CVD events because not enough events have accrued yet in the subgroup of MESA participants with genotyping results. However, it should be noted that other studies have found small differences in CIMT to be associated with significant differences in risk for myocardial infarction and stroke, 32, 33 suggesting that the association of rs10846744 with CCIMT also might have effects on CVD risk. It is also unclear whether certain SNPs with strong associations to SCA phenotypes in only 1 racial/ethnic group but not in others are the result of type I error or whether they represent true associations. To reduce the likelihood of observing false associations, we performed simulations that randomly shuffled phenotypes to derive P values corrected for multiple hypothesis testing, accounting for number of SNPs and phenotypes examined. This approach can limit the likelihood of observing false associations due to low minor allele frequencies, and because it is not as overly conservative as the Bonferroni correction (␣*ϭ0.0001 in this study), it is less likely to exclude true associations. Another inherent limitation in confirming whether associations in 1 racial/ethnic group but not another are true is the vast difference in the LD background among the MESA racial/ ethnic groups. Despite these limitations, at least 1 SNP, rs10846744, demonstrated consistency and uniform directionality in its association with CCIMT across multiple ethnic groups in both primary and sex-stratified analyses, suggesting a low likelihood of type 1 error with this result. Furthermore, to verify this observed association after confirming the absence of race/ethnicity-genotype interactions, we also pooled genotypes and tested association in the 4 groups to increase statistical power.
It is also unclear whether differences in the associations among racial/ethnic groups represent true differences perhaps because of undetected gene-gene or gene-environment interactions that could lead to variability in the significant associations of SCARB1 SNPs with lipid and SCA phenotypes. A potentially relevant gene-gene interaction previously observed is that of PON1 and SCARB1 on CVD in men. 18 However, a more probable source of inconsistency is that the genotyped SNPs were not the true causal variants but are in strong LD with the variants at the causal locus. With the large differences observed in allele frequencies in the LD backgrounds among the racial/ethnic groups, it is possible that an SNP could be a strong marker for the effect at a causal SNP on 1 LD background but not another. It is also possible that these associations are false-positives, which suggests that further examination of these associations in other studies with data on SCA is needed.
In summary, this study suggests that variation in SCARB1 is likely to play a role in SCA. However, the exact mechanism of this relationship and to what degree it may differ by sex remain unclear, and more work is needed to confirm this relationship and to determine whether it increases risk for incident CVD.
